<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Schmidt R</submitter><funding>NIGMS NIH HHS</funding><pagination>251</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3491406</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(10)</volume><pubmed_abstract>Somatic cell reprogramming to induced pluripotent stem (iPS) cells by defined factors is a form of engineered reverse development carried out in vitro. Recent investigation has begun to elucidate the molecular mechanisms whereby these factors function to reset the epigenome.</pubmed_abstract><journal>Genome biology</journal><pubmed_title>The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation.</pubmed_title><pmcid>PMC3491406</pmcid><funding_grant_id>T32 GM008042</funding_grant_id><funding_grant_id>P01 GM099134</funding_grant_id><pubmed_authors>Schmidt R</pubmed_authors><pubmed_authors>Plath K</pubmed_authors></additional><is_claimable>false</is_claimable><name>The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation.</name><description>Somatic cell reprogramming to induced pluripotent stem (iPS) cells by defined factors is a form of engineered reverse development carried out in vitro. Recent investigation has begun to elucidate the molecular mechanisms whereby these factors function to reset the epigenome.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Oct</publication><modification>2025-04-04T07:41:42.794Z</modification><creation>2019-06-05T17:49:17Z</creation></dates><accession>S-EPMC3491406</accession><cross_references><pubmed>23088445</pubmed><doi>10.1186/gb-2012-13-10-251</doi></cross_references></HashMap>